Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$1.6B
Avg Funding
$65.6M
Global Reach
5
countries

Top Cities for Biopharma

Copenhagen
Norwalk
Miami
Cambridge
Los Angeles
La Jolla

Recently Funded Companies

Export
Copenhagen, Denmark

BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.

$3.6M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Norwalk, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

$4.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Miami, United States

Veru is a biopharmaceutical company that specializes in developing novel medicines.

$25.2M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

$3.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Rarity is a biotechnology company that offers genetic treatments for immune diseases.

$4.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

La Jolla, United States

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

$825.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Chapel Hill, United States

iOrganBio is a pioneering cell production platform.

$2.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

$80.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Solna, Sweden

Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.

$12.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Woburn, United States

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

$39.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Woburn, United States

Vertero Therapeutics is using cutting-edge research outside of the brain to treat neurodegenerative illnesses.

$20.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Durham, United States

InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.

$1.9M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Animol Discovery is a biopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics.

$12.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Mekiri Bio is a biotechnology company.

$1.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

$254.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

New York, United States

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

$11.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Indapta Therapeutics is a privately held biotechnology company.

$50.8M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

$30.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Etobicoke, Canada

BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.

$1.4M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

$80.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Culver City, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

$96.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Hørsholm, Denmark

We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.

$1.3M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Rockville, United States

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

$50.0M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Genie Fertility is a company specializing in precision care for uterine health.

$1.2M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Dallas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

$29.4M raised
Sep 2025

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$65.6M
Total Funding Tracked
$1.6B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
2 companies$83.6M
2.Woburn
2 companies$59.6M
3.Boston
2 companies$13.0M
4.Copenhagen
1 companies$3.6M
5.Norwalk
1 companies$4.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked